scispace - formally typeset
U

Ulrich T. Hopt

Researcher at University of Freiburg

Publications -  349
Citations -  11279

Ulrich T. Hopt is an academic researcher from University of Freiburg. The author has contributed to research in topics: Pancreatitis & Pancreas. The author has an hindex of 50, co-authored 347 publications receiving 10112 citations. Previous affiliations of Ulrich T. Hopt include University Medical Center Freiburg.

Papers
More filters
Journal ArticleDOI

A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.

TL;DR: A liposomal formulation of Gemcitabine, GemLip, shows promising antitumoral activity on MIA PaCa-2 cells growing orthotopically in nude mice, and Surprisingly, empty liposomes attenuate the spread of metastases similar to Gem citabine and GemLips.
Journal ArticleDOI

Subcutaneous Redon drains do not reduce the incidence of surgical site infections after laparotomy. A randomized controlled trial on 200 patients

TL;DR: This is the first systematic randomized evaluation in patients undergoing laparotomy in visceral surgery to clarify whether widely used subcutaneous drains (Redon) affect wound infection as the primary outcome measure and could not demonstrate a reduction of SSI by the use of Redon drains.
Journal ArticleDOI

Short- and long-term results of duodenum preservation versus resection for the management of chronic pancreatitis: a prospective, randomized study.

TL;DR: Both types of pancreatic head resections are equally effective in pain relief and eventual quality of life after long-term follow-up (>5 years) without differences in endocrine or exocrine function.
Journal ArticleDOI

Comprehensive analysis of the α‐fetoprotein‐specific CD8+ T cell responses in patients with hepatocellular carcinoma

TL;DR: In patients with HCC, a high frequency of AFP‐specific CD8+ T cells directed against different epitopes suggest that AFP has a strong and broad immunogenicity, but also demonstrates a diversity of immune responses that may be needed for protection.
Journal ArticleDOI

Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.

TL;DR: Experimental data suggest an important role of epithelial‐mesenchymal transition (EMT) in invasion and metastasis of PDAC and biological and prognostic implications of EMT and tumor budding in PDAC of the pancreatic head are suggested.